HK Stock MarketDetailed Quotes

01696 SISRAM MED

Watchlist

3.360
+0.020+0.60%

Not Open Nov 21 18:11 CST

1.57BMarket Cap8.55P/E (TTM)

SISRAM MED Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(Q6)Jun 30, 2020

(FY)Dec 31, 2019

Turnover

-1.68%168.73M

1.36%359.29M

-1.65%171.62M

20.45%354.48M

39.28%174.5M

81.56%294.29M

74.66%125.29M

-6.58%162.1M

-16.03%71.74M

12.73%173.52M

Operating income

-1.68%168.73M

1.36%359.29M

-1.65%171.62M

20.45%354.48M

39.28%174.5M

81.56%294.29M

74.66%125.29M

-6.58%162.1M

-16.03%71.74M

12.73%173.52M

Cost of sales

4.38%-63.42M

8.20%-139.77M

11.44%-66.32M

-19.48%-152.25M

-39.16%-74.89M

-77.50%-127.43M

-69.05%-53.82M

7.54%-71.79M

12.69%-31.83M

-8.41%-77.65M

Operating expenses

4.38%-63.42M

8.20%-139.77M

11.44%-66.32M

-19.48%-152.25M

-39.16%-74.89M

-77.50%-127.43M

-69.05%-53.82M

7.54%-71.79M

12.69%-31.83M

-8.41%-77.65M

Gross profit

0.01%105.31M

8.55%219.53M

5.71%105.3M

21.19%202.23M

39.36%99.61M

84.78%166.86M

79.13%71.48M

-5.81%90.3M

-18.52%39.9M

16.50%95.87M

Selling expenses

-5.64%-63.23M

-25.74%-125.35M

-26.23%-59.86M

-26.35%-99.68M

-57.89%-47.42M

-83.11%-78.89M

-51.42%-30.03M

0.94%-43.09M

1.43%-19.83M

-33.17%-43.5M

Administrative expenses

-16.17%-16.3M

-17.26%-34.09M

-0.99%-14.03M

-33.28%-29.08M

-49.69%-13.89M

-37.43%-21.82M

-14.74%-9.28M

-0.26%-15.87M

-6.62%-8.09M

-7.17%-15.83M

Research and development expenses

11.90%-8.07M

-0.03%-18.03M

-9.97%-9.16M

-15.58%-18.02M

-3.47%-8.33M

-42.32%-15.59M

-62.46%-8.05M

-4.65%-10.96M

-0.22%-4.96M

-0.87%-10.47M

Operating interest expense

----

-11.73%-1.03M

-88.44%-2.01M

-164.66%-921K

---1.06M

---348K

----

Special items of operating profit

-529.97%-1.81M

76.31%-2.06M

95.05%-287K

-32.46%-8.71M

-108.07%-5.8M

-147.27%-6.58M

-885.16%-2.79M

-424.46%-2.66M

-19.92%-283K

32.76%-507K

Operating profit

-27.61%15.9M

-14.42%40M

-5.09%21.97M

11.33%46.74M

13.42%23.15M

151.94%41.98M

219.16%20.41M

-34.83%16.66M

-60.25%6.39M

7.76%25.57M

Financing cost

-14.56%-1.18M

-23.99%-2.45M

---1.03M

---1.97M

----

22.69%-729K

Share of profits of associates

99.52%-1K

19.19%-421K

-179.73%-207K

-69.71%-521K

72.59%-74K

---307K

---270K

----

Earning before tax

-28.98%14.72M

-16.08%37.13M

-10.14%20.73M

6.17%44.24M

14.58%23.07M

150.10%41.67M

214.94%20.14M

-32.92%16.66M

-58.94%6.39M

9.02%24.84M

Tax

21.96%-1.52M

-1.68%-4.23M

23.42%-1.95M

54.52%-4.16M

8.32%-2.55M

-361.76%-9.15M

-323.17%-2.78M

31.75%-1.98M

61.59%-656K

-204.72%-2.9M

After-tax profit from continuing operations

-29.71%13.2M

-17.92%32.9M

-8.50%18.78M

23.25%40.08M

18.24%20.53M

121.53%32.52M

202.56%17.36M

-33.07%14.68M

-58.62%5.74M

0.48%21.94M

Earning after tax

-29.71%13.2M

-17.92%32.9M

-8.50%18.78M

23.25%40.08M

18.24%20.53M

121.53%32.52M

202.56%17.36M

-33.07%14.68M

-58.62%5.74M

0.48%21.94M

Minority profit

2,039.66%2.25M

1,654.44%1.4M

-23.40%-116K

-107.06%-90K

-109.57%-94K

-4.57%1.28M

319.66%982K

16.17%1.34M

-64.33%234K

--1.15M

Profit attributable to shareholders

-42.05%10.95M

-21.59%31.5M

-8.35%18.9M

28.56%40.17M

25.90%20.62M

134.15%31.25M

197.58%16.38M

-35.80%13.34M

-58.33%5.5M

-4.79%20.79M

Basic earnings per share

-42.08%0.0234

-21.81%0.0674

-8.60%0.0404

24.93%0.0862

19.46%0.0442

128.48%0.069

198.39%0.037

-35.74%0.0302

-58.53%0.0124

-4.86%0.047

Diluted earnings per share

-41.94%0.0234

-21.84%0.0673

-8.82%0.0403

24.78%0.0861

19.46%0.0442

128.48%0.069

198.39%0.037

-35.74%0.0302

-58.53%0.0124

-4.86%0.047

Currency Unit

USD

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(Q6)Jun 30, 2020	(FY)Dec 31, 2019
Turnover	-1.68%168.73M	1.36%359.29M	-1.65%171.62M	20.45%354.48M	39.28%174.5M	81.56%294.29M	74.66%125.29M	-6.58%162.1M	-16.03%71.74M	12.73%173.52M
Operating income	-1.68%168.73M	1.36%359.29M	-1.65%171.62M	20.45%354.48M	39.28%174.5M	81.56%294.29M	74.66%125.29M	-6.58%162.1M	-16.03%71.74M	12.73%173.52M
Cost of sales	4.38%-63.42M	8.20%-139.77M	11.44%-66.32M	-19.48%-152.25M	-39.16%-74.89M	-77.50%-127.43M	-69.05%-53.82M	7.54%-71.79M	12.69%-31.83M	-8.41%-77.65M
Operating expenses	4.38%-63.42M	8.20%-139.77M	11.44%-66.32M	-19.48%-152.25M	-39.16%-74.89M	-77.50%-127.43M	-69.05%-53.82M	7.54%-71.79M	12.69%-31.83M	-8.41%-77.65M
Gross profit	0.01%105.31M	8.55%219.53M	5.71%105.3M	21.19%202.23M	39.36%99.61M	84.78%166.86M	79.13%71.48M	-5.81%90.3M	-18.52%39.9M	16.50%95.87M
Selling expenses	-5.64%-63.23M	-25.74%-125.35M	-26.23%-59.86M	-26.35%-99.68M	-57.89%-47.42M	-83.11%-78.89M	-51.42%-30.03M	0.94%-43.09M	1.43%-19.83M	-33.17%-43.5M
Administrative expenses	-16.17%-16.3M	-17.26%-34.09M	-0.99%-14.03M	-33.28%-29.08M	-49.69%-13.89M	-37.43%-21.82M	-14.74%-9.28M	-0.26%-15.87M	-6.62%-8.09M	-7.17%-15.83M
Research and development expenses	11.90%-8.07M	-0.03%-18.03M	-9.97%-9.16M	-15.58%-18.02M	-3.47%-8.33M	-42.32%-15.59M	-62.46%-8.05M	-4.65%-10.96M	-0.22%-4.96M	-0.87%-10.47M
Operating interest expense	----	----	----	----	-11.73%-1.03M	-88.44%-2.01M	-164.66%-921K	---1.06M	---348K	----
Special items of operating profit	-529.97%-1.81M	76.31%-2.06M	95.05%-287K	-32.46%-8.71M	-108.07%-5.8M	-147.27%-6.58M	-885.16%-2.79M	-424.46%-2.66M	-19.92%-283K	32.76%-507K
Operating profit	-27.61%15.9M	-14.42%40M	-5.09%21.97M	11.33%46.74M	13.42%23.15M	151.94%41.98M	219.16%20.41M	-34.83%16.66M	-60.25%6.39M	7.76%25.57M
Financing cost	-14.56%-1.18M	-23.99%-2.45M	---1.03M	---1.97M	----	----	----	----	----	22.69%-729K
Share of profits of associates	99.52%-1K	19.19%-421K	-179.73%-207K	-69.71%-521K	72.59%-74K	---307K	---270K	----	----	----
Earning before tax	-28.98%14.72M	-16.08%37.13M	-10.14%20.73M	6.17%44.24M	14.58%23.07M	150.10%41.67M	214.94%20.14M	-32.92%16.66M	-58.94%6.39M	9.02%24.84M
Tax	21.96%-1.52M	-1.68%-4.23M	23.42%-1.95M	54.52%-4.16M	8.32%-2.55M	-361.76%-9.15M	-323.17%-2.78M	31.75%-1.98M	61.59%-656K	-204.72%-2.9M
After-tax profit from continuing operations	-29.71%13.2M	-17.92%32.9M	-8.50%18.78M	23.25%40.08M	18.24%20.53M	121.53%32.52M	202.56%17.36M	-33.07%14.68M	-58.62%5.74M	0.48%21.94M
Earning after tax	-29.71%13.2M	-17.92%32.9M	-8.50%18.78M	23.25%40.08M	18.24%20.53M	121.53%32.52M	202.56%17.36M	-33.07%14.68M	-58.62%5.74M	0.48%21.94M
Minority profit	2,039.66%2.25M	1,654.44%1.4M	-23.40%-116K	-107.06%-90K	-109.57%-94K	-4.57%1.28M	319.66%982K	16.17%1.34M	-64.33%234K	--1.15M
Profit attributable to shareholders	-42.05%10.95M	-21.59%31.5M	-8.35%18.9M	28.56%40.17M	25.90%20.62M	134.15%31.25M	197.58%16.38M	-35.80%13.34M	-58.33%5.5M	-4.79%20.79M
Basic earnings per share	-42.08%0.0234	-21.81%0.0674	-8.60%0.0404	24.93%0.0862	19.46%0.0442	128.48%0.069	198.39%0.037	-35.74%0.0302	-58.53%0.0124	-4.86%0.047
Diluted earnings per share	-41.94%0.0234	-21.84%0.0673	-8.82%0.0403	24.78%0.0861	19.46%0.0442	128.48%0.069	198.39%0.037	-35.74%0.0302	-58.53%0.0124	-4.86%0.047
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

01696 SISRAM MED

SISRAM MED Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target